{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:14:21Z","timestamp":1778710461909,"version":"3.51.4"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232115"],"award-info":[{"award-number":["7232115"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cca.2025.120186","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T17:35:28Z","timestamp":1739122528000},"page":"120186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Unmasking primary aldosteronism: Transforming disease management with advanced steroid profiling"],"prefix":"10.1016","volume":"570","author":[{"given":"Jian","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tashi","family":"Paljor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SongLin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tem.2021.10.002","article-title":"Pathophysiology and histopathology of primary aldosteronism","volume":"33","author":"Williams","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.cca.2025.120186_b0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism \u2014 a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"16","key":"10.1016\/j.cca.2025.120186_b0015","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary Aldosteronism in Patients in China With Recently Detected Hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.cca.2025.120186_b0020","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in PrimaryCarePractice","volume":"69","author":"Monticone","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism","volume":"173","author":"Brown","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.cca.2025.120186_b0030","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0035","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0040","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(17)30368-6","article-title":"Primary aldosteronism and cardiovascular risk, before and after treatment","volume":"6","author":"J.W. Funder","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/cvr\/cvac027","article-title":"Aldosterone and cardiovascular diseases","volume":"119","author":"Parksook","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0055","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.121.18342","article-title":"Higher Plasma Aldosterone Concentrations Are Associated With Elevated Risk of Aortic Dissection and Aneurysm: a Case-Control Study","volume":"79","author":"Zhu","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"10.1016\/j.cca.2025.120186_b0065","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41574-020-0382-4","article-title":"Pathogenesis and treatment of primary aldosteronism","volume":"16","author":"Zennaro","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0070","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.5842","article-title":"Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism","volume":"154","author":"Vorselaars","year":"2019","journal-title":"JAMA Surg."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/endrev\/bnad024","article-title":"Biomarkers to Guide Medical Therapy in Primary Aldosteronism","volume":"45","author":"Hundemer","year":"2024","journal-title":"Endocr. Rev."},{"issue":"10","key":"10.1016\/j.cca.2025.120186_b0085","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0090","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr. J."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ando.2016.05.001","article-title":"SFE\/SFHTA\/AFCE primary aldosteronism consensus: Introduction and handbook","volume":"77","author":"Amar","year":"2016","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.cca.2025.120186_b0100","doi-asserted-by":"crossref","unstructured":"M. Funes Hernandez, V. Bhalla, Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection, American Journal of Kidney Diseases 82(3) (2023) 333-346. doi:10.1053\/j.ajkd.2023.01.447.","DOI":"10.1053\/j.ajkd.2023.01.447"},{"key":"10.1016\/j.cca.2025.120186_b0105","doi-asserted-by":"crossref","unstructured":"J.B. Cohen, D.L. Cohen, D.S. Herman, J.T. Leppert, J.B. Byrd, V. Bhalla, Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans, Annals of Internal Medicine 174(3) (2021) 289-297. doi:10.7326\/m20-4873.","DOI":"10.7326\/M20-4873"},{"key":"10.1016\/j.cca.2025.120186_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.684111","article-title":"The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism","volume":"12","author":"J\u0119drusik","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism: Implications for Case Detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.cca.2025.120186_b0120","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0125","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1210\/clinem\/dgz092","article-title":"Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism","volume":"105","author":"Nagano","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.cca.2025.120186_b0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a Specialized Clinic on Rates of Investigation and Treatment of Primary Aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg."},{"issue":"7","key":"10.1016\/j.cca.2025.120186_b0135","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1210\/clinem\/dgad044","article-title":"Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis","volume":"108","author":"Sconfienza","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/clinchem\/hvae022","article-title":"Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives","volume":"70","author":"Courcelles","year":"2024","journal-title":"Clin. Chem."},{"issue":"12","key":"10.1016\/j.cca.2025.120186_b0145","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s40618-021-01615-3","article-title":"Frequently asked questions and answers (if any) in patients with adrenal incidentaloma","volume":"44","author":"Ceccato","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"10.1016\/j.cca.2025.120186_b0150","first-page":"1835","article-title":"Application of the steroid profiling detecting by LC-MS\/MS in the diagnosis of primary aldosteronism","volume":"42","author":"Gao","year":"2022","journal-title":"Basic and Clinical Medicine"},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2025.120186_b0160","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.118.11243","article-title":"Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions","volume":"72","author":"Sugiura","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2025.120186_b0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchromb.2019.03.012","article-title":"Establishment of a rapid and simple liquid chromatography tandem mass spectrometry method for measuring aldosterone in urine","volume":"1113","author":"Yin","year":"2019","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11154-007-9052-2","article-title":"Basic concepts and recent developments in human steroid hormone biosynthesis","volume":"8","author":"Ghayee","year":"2007","journal-title":"Rev Endocr Metab Dis"},{"key":"10.1016\/j.cca.2025.120186_b0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02155834","article-title":"Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel","author":"Simpson","year":"1953","journal-title":"Experientia 9(9)"},{"key":"10.1016\/j.cca.2025.120186_b0180","doi-asserted-by":"crossref","unstructured":"C. JW., L.H. Louis, Primary Aldosteronism, a New Clinical Entity, Annals of Internal Medicine 44(1) (1956) 1-15. doi:10.7326\/0003-4819-44-1-1.","DOI":"10.7326\/0003-4819-44-1-1"},{"key":"10.1016\/j.cca.2025.120186_b0185","unstructured":"C. JW, Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome, J Lab Clin Med 45(1) (1955) 3-17."},{"issue":"10","key":"10.1016\/j.cca.2025.120186_b0190","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220903","article-title":"Induction of natural IgE by glucocorticoids","volume":"219","author":"Lim","year":"2022","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.00021.2023","article-title":"Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries","volume":"104","author":"Martinez","year":"2024","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.tem.2010.05.004","article-title":"Cellular mechanisms of estradiol-mediated sexual differentiation of the brain","volume":"21","author":"Wright","year":"2010","journal-title":"Trends Endocrin Met"},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11154-022-09756-3","article-title":"Development and function of the fetal adrenal","volume":"24","author":"Pignatti","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"11","key":"10.1016\/j.cca.2025.120186_b0215","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tem.2017.09.002","article-title":"Steroidogenesis: Unanswered Questions","volume":"28","author":"Miller","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cca.2025.120186_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105439","article-title":"Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review","volume":"194","author":"Schiffer","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/edrv-3-3-299","article-title":"The Role of Lipoproteins in Steroidogenesis and Cholesterol Metabolism in Steroidogenic Glands*","volume":"3","author":"Gwynne","year":"1982","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0230","first-page":"221","article-title":"Regulation of the acute production of steroids in steroidogenic cells","volume":"17","author":"Stocco","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2025.120186_b0235","first-page":"1017","article-title":"Regulation of Aldosterone Synthesis and Secretion","author":"Bollag","year":"2014","journal-title":"Compr. Physiol."},{"issue":"10","key":"10.1016\/j.cca.2025.120186_b0240","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1515\/BC.2002.174","article-title":"The Human Steroid Hydroxylases CYP11B1 and CYP11B2","volume":"383","author":"Bureik","year":"2002","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0245","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/HYPERTENSIONAHA.122.20515","article-title":"Phosphoproteomics Reveals the Wolframin-Calcium Axis as an Important Pathogenic Signaling Node in Primary Aldosteronism","volume":"80","author":"Ma","year":"2023","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0303-7207(79)90082-0","article-title":"Cholesterol Side-Chain Cleavage, Cytochrome-P450, and the Control of Steroidogenesis","volume":"13","author":"Simpson","year":"1979","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120186_b0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cca.2025.120186_b0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsbmb.2014.10.011","article-title":"The CYP11B subfamily","volume":"151","author":"Schiffer","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0265","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-17-0563","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?","volume":"178","author":"Lenders","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0270","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1002\/j.2040-4603.2023.tb00256.x","article-title":"Aldosterone: Renal Action and Physiological Effects","volume":"13","author":"Johnston","year":"2023","journal-title":"Compr Physiol"},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.kint.2022.12.021","article-title":"New advances in endocrine hypertension: from genes to biomarkers","volume":"103","author":"Fernandes-Rosa","year":"2023","journal-title":"Kidney Int."},{"issue":"1688","key":"10.1016\/j.cca.2025.120186_b0280","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1098\/rspb.2009.2148","article-title":"Origin of ultradian pulsatility in the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"277","author":"Walker","year":"2010","journal-title":"Proc. R. Soc. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0285","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.ph.50.030188.002235","article-title":"Regulation of the Synthesis of Steroidogenic Enzymes in Adrenal Cortical Cells by ACTH","volume":"50","author":"Simpson","year":"1988","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/beem.2000.0119","article-title":"Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase","volume":"15","author":"Tomlinson","year":"2001","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0295","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/HYPERTENSIONAHA.121.17615","article-title":"Aldosterone Synthase Structure With Cushing Disease Drug LCI699 Highlights Avenues for Selective CYP11B Drug Design","volume":"78","author":"Brixius-Anderko","year":"2021","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0300","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1210\/jc.2004-0379","article-title":"Studies on the Origin of Circulating 18-Hydroxycortisol and 18-Oxocortisol in Normal Human Subjects","volume":"89","author":"Freel","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1172\/JCI104239","article-title":"The disappearance of 7-H-3-d-aldosterone in the plasma of normal subjects","volume":"40","author":"Tait","year":"1961","journal-title":"J. Clin. Investig."},{"issue":"07\/08","key":"10.1016\/j.cca.2025.120186_b0310","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/a-2054-1062","article-title":"An Abbreviated History of Aldosterone Metabolism, Current and Future Challenges","volume":"131","author":"Gomez-Sanchez","year":"2023","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0315","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/edrv-2-2-234","article-title":"The Metabolism and Mechanism of Action of Aldosterone","volume":"2","author":"Morris","year":"1981","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0320","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/j.2040-4603.2014.tb00569.x","article-title":"The multifaceted mineralocorticoid receptor","volume":"4","author":"Gomez-Sanchez","year":"2014","journal-title":"Compr Physiol"},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0325","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem-25-2-219","article-title":"Splanchnic Extraction and Clearance of Aldosterone in Subjects with Minimal and Marked Cardiac Dysfunction1","volume":"25","author":"Tait","year":"1965","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0330","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1210\/jcem-52-2-214","article-title":"Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients","volume":"52","author":"Gomez-Sanchezf","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0335","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-9378(82)90389-1","article-title":"Urinary free 18-hydroxycorticosterone, plasma aldosterone, and urinary aldosterone metabolites in normal pregnancy","volume":"144","author":"Bauknecht","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2025.120186_b0340","doi-asserted-by":"crossref","first-page":"15733","DOI":"10.1002\/chem.202004154","article-title":"Aldosterone Glucuronide, an Important Biomarker: Synthesis and Structure Elucidation of Novel Isomers","author":"Guha","year":"2020","journal-title":"Chemistry \u2013 A European Journal 26(67)"},{"issue":"6","key":"10.1016\/j.cca.2025.120186_b0345","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1210\/en.2002-0052","article-title":"Human Uridine Diphosphate-Glucuronosyltransferase UGT2B7 Conjugates Mineralocorticoid and Glucocorticoid Metabolites","volume":"144","author":"Girard","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2025.120186_b0350","doi-asserted-by":"crossref","unstructured":"S.A. Latif, D.J. Morris, L. Wei, D.N. Kirk, P.J. Burke, H.C. Toms, C.H.L. Shackleton, 18-Substituted steroids\u2014part 17. 2\u03b1-hydroxylated liver metabolites of aldosterone identified by high-field [1H]NMR spectroscopy, Journal of Steroid Biochemistry 33(6) (1989) 1119-1125. doi:10.1016\/0022-4731(89)90418-4.","DOI":"10.1016\/0022-4731(89)90418-4"},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0355","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/cs0570409","article-title":"Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension","volume":"57","author":"Abdelhamid","year":"1979","journal-title":"Clin Sci (lond)"},{"issue":"6","key":"10.1016\/j.cca.2025.120186_b0360","first-page":"551","article-title":"Isolation of aldosterone urinary metabolites, glucuronides and sulfate","volume":"4","author":"Grose","year":"1973","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0365","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0022-4731(83)90068-7","article-title":"Aldosterone 21-sulphate in man","volume":"18","author":"Jowett","year":"1983","journal-title":"J. Steroid Biochem."},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1985.tb01074.x","article-title":"Clinical Significance of Unconjugated 3\u03b1,5\u03b2\u2010Tetrahydroaldosterone and 5\u03b2\u2010Dihydroaldosterone Measured by Radioimmunoassay","volume":"22","author":"Lewicka","year":"2008","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0375","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension","volume":"167","author":"Brown","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0380","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/HYPERTENSIONAHA.123.21983","article-title":"Long-Term Follow-Up of Patients With Elevated Aldosterone-to-Renin Ratio but Negative Confirmatory Test: The Progression of Primary Aldosteronism Phenotypes","volume":"81","author":"Buffolo","year":"2024","journal-title":"Hypertension"},{"key":"#cr-split#-10.1016\/j.cca.2025.120186_b0385.1","unstructured":"C.S.o. Endocrinology, Expert consensus on the diagnosis and treatment of primary aldosteronism (2020), Chinese Society of Endocrinology 32"},{"key":"#cr-split#-10.1016\/j.cca.2025.120186_b0385.2","unstructured":"(3) (2020) 188-195. doi:10.3760\/cma.j.cn311282-20200615-00444."},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0390","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5551\/jat.24455","article-title":"Comparison of Cardiovascular Complications in Patients with and without <i>KCNJ5<\/i> Gene Mutations Harboring Aldosterone-producing Adenomas","volume":"22","author":"Kitamoto","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0395","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical Characteristics of Somatic Mutations in Chinese Patients With Aldosterone-Producing Adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0400","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.cca.2025.120186_b0405","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.118.12064","article-title":"18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status","volume":"73","author":"Tezuka","year":"2019","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.cca.2025.120186_b0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0337-9","article-title":"Genetic causes of primary aldosteronism","volume":"51","author":"Seidel","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.cca.2025.120186_b0415","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0420","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0425","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.cca.2025.120186_b0430","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","volume":"83","author":"Scholl","year":"2015","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"10.1016\/j.cca.2025.120186_b0435","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1210\/en.2015-1466","article-title":"Pathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na+\/K+-ATPase","volume":"156","author":"Bandulik","year":"2015","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.cca.2025.120186_b0440","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/en.2015-2029","article-title":"Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca2+-ATPase ATP2B3","volume":"157","author":"Tauber","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2025.120186_b0445","doi-asserted-by":"crossref","unstructured":"A.E.D. Teo, S. Garg, L. Haris Shaikh, J. Zhou, F.E. Karet Frankl, M. Gurnell, L. Happerfield, A. Marker, M. Bienz, E.A.B. Azizan, M.J. Brown, Pregnancy, Primary Aldosteronism, and AdrenalCTNNB1Mutations, New Engl J Med 373(15) (2015) 1429-1436. doi:10.1056\/NEJMoa1504869.","DOI":"10.1056\/NEJMoa1504869"},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0450","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120186_b0455","doi-asserted-by":"crossref","unstructured":"J. Zhou, E.A.B. Azizan, C.P. Cabrera, F.L. Fernandes-Rosa, S. Boulkroun, G. Argentesi, E. Cottrell, L. Amar, X. Wu, S. O\u2019Toole, E. Goodchild, A. Marker, R. Senanayake, S. Garg, T. \u00c5kerstr\u00f6m, S. Backman, S. Jordan, S. Polubothu, D.M. Berney, A. Gluck, K.E. Lines, R.V. Thakker, A. Tuthill, C. Joyce, J.P. Kaski, F.E. Karet Frankl, L.A. Metherell, A.E.D. Teo, M. Gurnell, L. Parvanta, W.M. Drake, E. Wozniak, D. Klinzing, J.L. Kuan, Z. Tiang, C.E. Gomez Sanchez, P. Hellman, R.S.Y. Foo, C.A. Mein, V.A. Kinsler, P. Bj\u00f6rklund, H.L. Storr, M.-C. Zennaro, M.J. Brown, Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause, Nature Genetics 53(9) (2021) 1360-1372. doi:10.1038\/s41588-021-00906-y.","DOI":"10.1038\/s41588-021-00906-y"},{"key":"10.1016\/j.cca.2025.120186_b0460","doi-asserted-by":"crossref","unstructured":"J.W. Funder, Primary Aldosteronism, Hypertension 74(3) (2019) 458-466. doi:10.1161\/hypertensionaha.119.12935.","DOI":"10.1161\/HYPERTENSIONAHA.119.12935"},{"key":"10.1016\/j.cca.2025.120186_b0465","doi-asserted-by":"crossref","unstructured":"R.P. Lifton, M. Dluhy Rg Fau - Powers, G.M. Powers M Fau - Rich, S. Rich Gm Fau - Cook, S. Cook S Fau - Ulick, J.M. Ulick S Fau - Lalouel, J.M. Lalouel, A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension, Nature 355(6357) (1992) 262-265. doi:10.1038\/355262a0.","DOI":"10.1038\/355262a0"},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0470","doi-asserted-by":"crossref","first-page":"134","DOI":"10.21856\/j-PEP.2020.1.18","article-title":"Primary Hyperaldosteronism as a Rare Cause of Hypokalemia","volume":"71","author":"Kurtkulagi","year":"2020","journal-title":"Problems of Endocrine Pathology"},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0475","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/clinem\/dgac679","article-title":"Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening","volume":"108","author":"Maciel","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0480","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism","volume":"108","author":"Ng","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0485","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005574","article-title":"Quantitative Value of Aldosterone\u2010Renin Ratio for Detection of Aldosterone\u2010Producing Adenoma: The Aldosterone\u2010Renin Ratio for Primary Aldosteronism (AQUARR) Study","volume":"6","author":"Maiolino","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0490","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1291\/hypres.30.111","article-title":"Prevalence of Primary Aldosteronism among Unselected Hypertensive Patients: A Prospective Study Based on the Use of an Aldosterone\/Renin Ratio above 25 as a Screening Test","volume":"30","author":"Fogari","year":"2007","journal-title":"Hypertens. Res."},{"issue":"8","key":"10.1016\/j.cca.2025.120186_b0495","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.mayocp.2023.04.023","article-title":"Primary Aldosteronism: A Pragmatic Approach to Diagnosis and Management","volume":"98","author":"Dogra","year":"2023","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.cca.2025.120186_b0500","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the Renin\/Aldosterone Profile under Random and Standardized Sampling Conditions in Primary Aldosteronism","volume":"88","author":"Tanabe","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2025.120186_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106596","article-title":"Pre-analytical stability and physiological fluctuations affect plasma steroid hormone outcomes: A real-world study","volume":"244","author":"Zhong","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"701","key":"10.1016\/j.cca.2025.120186_b0510","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg8464","article-title":"High-resolution daily profiles of tissue adrenal steroids by portable automated collection","volume":"15","author":"Upton","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0515","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1172\/JCI107414","article-title":"Circadian Rhythm of Plasma Aldosterone Concentration in Patients with Primary Aldosteronism","volume":"52","author":"Kem","year":"1973","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0520","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpaa151","article-title":"Variability of Aldosterone Measurements During Adrenal Venous Sampling for Primary Aldosteronism","volume":"34","author":"Yozamp","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2025.120186_b0525","doi-asserted-by":"crossref","unstructured":"W.C. Meijers, A.R. van der Velde, A.C. Muller Kobold, J. Dijck\u2010Brouwer, A.H. Wu, A. Jaffe, R.A. de Boer, Variability of biomarkers in patients with chronic heart failure and healthy controls, Eur J Heart Fail 19(3) (2016) 357-365. doi:10.1002\/ejhf.669.","DOI":"10.1002\/ejhf.669"},{"key":"10.1016\/j.cca.2025.120186_b0530","doi-asserted-by":"crossref","unstructured":"O. Ahokoski, V. Virtanen A Fau - Kairisto, H. Kairisto V Fau - Scheinin, R. Scheinin H Fau - Huupponen, K. Huupponen R Fau - Irjala, K. Irjala, Biological day-to-day variation and reference change limits of serum cortisol and aldosterone in healthy young men on unrestricted diets, Clinical Chemistry (0009-9147 (Print)) (1997) 1097-1099. doi:10.1093\/clinchem\/45.7.1097.","DOI":"10.1093\/clinchem\/45.7.1097"},{"issue":"8","key":"10.1016\/j.cca.2025.120186_b0535","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1253\/circj.CJ-10-1083","article-title":"Relationship Between Biological Variation in B-Type Natriuretic Peptide and Plasma Renin Concentration in Stable Outpatients With Dilated Cardiomyopathy","volume":"75","author":"Nishiyama","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.cca.2025.120186_b0540","doi-asserted-by":"crossref","unstructured":"W.A. Bartlett, F. Braga, A. Carobene, A. Co\u015fkun, R. Prusa, P. Fernandez-Calle, T. R\u00f8raas, N. Jonker, S. Sandberg, V. on behalf of the Biological, A checklist for critical appraisal of studies of biological variation, Clinical Chemistry and Laboratory Medicine (CCLM) 53(6) (2015) 879-885. doi:10.1515\/cclm-2014-1127.","DOI":"10.1515\/cclm-2014-1127"},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0545","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1373\/clinchem.2017.281808","article-title":"The Biological Variation Data Critical Appraisal Checklist: A Standard for Evaluating Studies on Biological Variation","volume":"64","author":"Sandberg","year":"2018","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0550","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and Application of Data on Biological Variation in Clinical Chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0555","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","article-title":"Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism","volume":"34","author":"Burrello","year":"2016","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.cca.2025.120186_b0560","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2018-01041","article-title":"Aldosterone LC-MS\/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism","volume":"103","author":"Guo","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0565","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/cclm-2019-0706","article-title":"Comparison of three different chemiluminescence assays and a rapid liquid chromatography tandem mass spectrometry method for measuring serum aldosterone","volume":"58","author":"Yin","year":"2019","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"7","key":"10.1016\/j.cca.2025.120186_b0570","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/HJH.0000000000001735","article-title":"Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography\u2013tandem mass spectrometry determinations of plasma aldosterone concentration","volume":"36","author":"Baron","year":"2018","journal-title":"J. Hypertens."},{"issue":"8","key":"10.1016\/j.cca.2025.120186_b0575","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight"},{"issue":"06","key":"10.1016\/j.cca.2025.120186_b0580","first-page":"435","article-title":"Is Primary Aldosteronism Associated with Diabetes Mellitus?","volume":"42","author":"Reincke","year":"2010","journal-title":"Results of the German Conn's Registry, Horm Metab Res"},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0585","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2025.120186_b0590","article-title":"Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0595","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/15622975.2012.665480","article-title":"Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study","volume":"15","author":"Apostolopoulou","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0600","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"33","key":"10.1016\/j.cca.2025.120186_b0605","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0610","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and Genetic Causes of Idiopathic Hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0615","doi-asserted-by":"crossref","first-page":"e1181","DOI":"10.1210\/clinem\/dgab751","article-title":"Plasma Steroid Profiling in Patients With Adrenal Incidentaloma","volume":"107","author":"Berke","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0620","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.119.14041","article-title":"Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism","volume":"75","author":"Sun","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0625","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-Related Autonomous Aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation"},{"issue":"3\u20135","key":"10.1016\/j.cca.2025.120186_b0630","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jsbmb.2010.02.017","article-title":"Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS\/MS becoming an essential tool for patient diagnosis","volume":"121","author":"Shackleton","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9\u201310","key":"10.1016\/j.cca.2025.120186_b0635","first-page":"2289","article-title":"LC\u2013MS\/MS in the routine clinical laboratory: has its time come?","volume":"406","author":"Leung","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2025.120186_b0640","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jmsacl.2022.07.006","article-title":"Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability","volume":"25","author":"Vogg","year":"2022","journal-title":"Journal of Mass Spectrometry and Advances in the Clinical Lab"},{"issue":"5","key":"10.1016\/j.cca.2025.120186_b0645","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1515\/cclm-2023-0250","article-title":"A novel LC-MS\/MS-based assay for the simultaneous quantification of aldosterone-related steroids in human urine","volume":"62","author":"Vogg","year":"2024","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"12","key":"10.1016\/j.cca.2025.120186_b0650","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1373\/clinchem.2017.277624","article-title":"A 13-Steroid Serum Panel Based on LC-MS\/MS: Use in Detection of Adrenocortical Carcinoma","volume":"63","author":"Taylor","year":"2017","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0655","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00216-023-05019-5","article-title":"Differentiation of steroid isomers by steroid analogues adducted trapped ion mobility spectrometry-mass spectrometry","volume":"416","author":"Li","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0660","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13361-016-1525-7","article-title":"Experimental and Theoretical Investigation of Sodiated Multimers of Steroid Epimers with Ion Mobility-Mass Spectrometry","volume":"28","author":"Chouinard","year":"2016","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"7","key":"10.1016\/j.cca.2025.120186_b0665","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1021\/acs.analchem.9b05247","article-title":"Interlaboratory and Interplatform Study of Steroids Collision Cross Section by Traveling Wave Ion Mobility Spectrometry","volume":"92","author":"Hern\u00e1ndez-Mesa","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2025.120186_b0670","doi-asserted-by":"crossref","unstructured":"W.J. Griffiths, Y. Wang, Sterolomics in biology, biochemistry, medicine, TrAC Trends in Analytical Chemistry 120(0165-9936 (Print)) (2019) 115280. doi:10.1016\/j.trac.2018.10.016.","DOI":"10.1016\/j.trac.2018.10.016"},{"issue":"2","key":"10.1016\/j.cca.2025.120186_b0675","doi-asserted-by":"crossref","first-page":"179","DOI":"10.33549\/physiolres.934124","article-title":"A method for determination of one hundred endogenous steroids in human serum by gas chromatography-tandem mass spectrometry","volume":"68","author":"Hill","year":"2019","journal-title":"Physiol. Res."},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0680","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1210\/clinem\/dgz141","article-title":"Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma","volume":"105","author":"Chortis","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.cca.2025.120186_b0685","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.3390\/molecules27185796","article-title":"GC-MS\/MS Determination of Steroid Hormones in Urine Using Solid-Phase Derivatization as an Alternative to Conventional Methods","volume":"27","author":"Temerdashev","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.cca.2025.120186_b0690","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1210\/jc.2013-3375","article-title":"Requirement for Mass Spectrometry Sex Steroid Assays in the Journal of Clinical Endocrinology and Metabolism","volume":"98","author":"Handelsman","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2025.120186_b0695","doi-asserted-by":"crossref","unstructured":"D. Unsihuay, D. Mesa Sanchez, J. Laskin, Quantitative Mass Spectrometry Imaging of Biological Systems, Annual Review of Physical Chemistry 72(1) (2021) 307-329. doi:10.1146\/annurev-physchem-061020-053416.","DOI":"10.1146\/annurev-physchem-061020-053416"},{"issue":"23","key":"10.1016\/j.cca.2025.120186_b0700","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1021\/ac970888i","article-title":"Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS","volume":"69","author":"Caprioli","year":"1997","journal-title":"Anal Chem"},{"issue":"14","key":"10.1016\/j.cca.2025.120186_b0705","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1021\/acs.analchem.9b00619","article-title":"Tandem Mass Spectrometry Imaging Reveals Distinct Accumulation Patterns of Steroid Structural Isomers in Human Adrenal Glands","volume":"91","author":"Takeo","year":"2019","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0710","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1021\/acs.analchem.9b04618","article-title":"Enhancement of On-tissue Chemical Derivatization by Laser-Assisted Tissue Transfer for MALDI MS Imaging","volume":"92","author":"Guo","year":"2019","journal-title":"Anal. Chem."},{"issue":"48","key":"10.1016\/j.cca.2025.120186_b0715","doi-asserted-by":"crossref","first-page":"17843","DOI":"10.1021\/acs.analchem.3c03931","article-title":"Revealing Structure and Localization of Steroid Regioisomers through Predictive Fragmentation Patterns in Mass Spectrometry Imaging","volume":"95","author":"Sharma","year":"2023","journal-title":"Anal. Chem."},{"issue":"14","key":"10.1016\/j.cca.2025.120186_b0720","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1039\/c4an00504j","article-title":"Matrix effects in biological mass spectrometry imaging: identification and compensation","volume":"139","author":"Lanekoff","year":"2014","journal-title":"Analyst"},{"issue":"8","key":"10.1016\/j.cca.2025.120186_b0725","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1515\/cclm-2016-0841","article-title":"Evaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS\/MS","volume":"55","author":"Lin","year":"2017","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"12","key":"10.1016\/j.cca.2025.120186_b0730","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/clinchem\/hvad146","article-title":"Androgen Excess and Deficiency: Analytical and Diagnostic Approaches","volume":"69","author":"Heijboer","year":"2023","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cca.2025.120186_b0735","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1515\/cclm-2016-0707","article-title":"In defense of aldosterone measurement by immunoassay: a broader perspective","volume":"55","author":"Blocki","year":"2017","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"10.1016\/j.cca.2025.120186_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117301","article-title":"Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors","volume":"543","author":"Vogg","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0745","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8090314","article-title":"The Potential of Steroid Profiling by Mass Spectrometry in the Management of Adrenocortical Carcinoma","volume":"8","author":"Rossi","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cca.2025.120186_b0750","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.cca.2025.120186_b0755","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41440-023-01347-2","article-title":"Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC\u2013MS\/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol","volume":"46","author":"Chang","year":"2023","journal-title":"Hypertens. Res."},{"issue":"9","key":"10.1016\/j.cca.2025.120186_b0760","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.cca.2025.120186_b0765","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","article-title":"Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism","volume":"72","author":"Meyer","year":"2018","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.cca.2025.120186_b0770","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1373\/clinchem.2017.271106","article-title":"High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders","volume":"63","author":"Hines","year":"2017","journal-title":"Clin. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:58:09Z","timestamp":1778709489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":155,"alternative-id":["S0009898125000658"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120186","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmasking primary aldosteronism: Transforming disease management with advanced steroid profiling","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120186"}}